Here, we used flow cytometry to quantitate the percentage of active NOTCH1-ICN in CD34+/CD38− HSCs and CD34+CD38+ progenitors from the BM of CLL patients and HDs, used as control. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.